Germany and India based DaaS (Data as a Service) startup, Innoplexus has secured an undisclosed amount in its Pre-Series A round of funding from HCS, a Germany-based Venture Capital Fund. Post the investment, Hans-Christian Semmler, Managing shareholder of HCS will join as Chairman of the supervisory board of Innoplexus.
The startup plans to deploy the raised funds to file patent applications, develop its trademark platform, iPlexus, and for marketing purposes.
Launched as a bootstrapped startup in 2011 by Dr. Gunjan Bhardwaj and Gaurav Tripathi, Innoplexus is a consulting-led technology and product development company focussed on big data and analytics. It helps Life Sciences companies generate actionable insights across pre-clinical, clinical, regulatory, and commercial stages of a drug.
As per an official statement, it’s DaaS engine provides its users with real-time data and insights and its Continuous Analytics as a Service (CAaaS) applications help enterprises make better data-driven decisions.
Commenting on the development, Dr. Gunjan Bhardwaj, co-Founder and CEO, Innoplexus said, “We envision to fundamentally transform the Data as a Service landscape for Life Sciences by leveraging machine learning and Artificial Intelligence to generate insights from the public as well as enterprise data.”
Headquartered in Germany, with over 100 employees working from Pune, Innoplexus services large global pharma & life sciences companies, many of which are Fortune 500 companies, as per its official website.